The team
Scientists and engineers building prediction you can trace
Simaya brings together mechanistic biology, causal modeling, and machine learning - led by oncology, clinical-development, and AI-engineering veterans - to solve patient-level drug prediction.
YG
Dr. Yair Glazer
CEO & Co-Founder
IA
Prof. Itzhak Avital
CMO & Co-Founder
AS
Amit Shmoshkin
CTO & Co-Founder
Advisors
Scientific & strategic advisors
Guiding Simaya across oncology, regulation, pharma strategy, and data science.
AS
Prof. Alex Stojadinovic
Professor of surgery & Medical director
JL
Prof. Jonathan Lewis
Executive Chairman of biotech
JL
Prof. Larry Norton
Senior VP, Office of the Hospital President
IS
Dr. Ilan Sason
CEO & Co-Founder
DSG.AI